tradingkey.logo

Bioventus Inc

BVS
查看详细走势图
7.460USD
+0.080+1.08%
收盘 12/26, 16:00美东报价延迟15分钟
499.62M总市值
47.61市盈率 TTM

Bioventus Inc

7.460
+0.080+1.08%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+1.08%

5天

-0.40%

1月

-2.48%

6月

+10.19%

今年开始到现在

-28.95%

1年

-29.76%

查看详细走势图

TradingKey Bioventus Inc股票评分

单位: USD 更新时间: 2025-12-26

操作建议

Bioventus Inc当前公司基本面数据相对稳定,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名28/207位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价15.00。中期看,股价处于上升通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Bioventus Inc评分

相关信息

行业排名
28 / 207
全市场排名
108 / 4563
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 3 位分析师
买入
评级
15.000
目标均价
+108.62%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

Bioventus Inc亮点

亮点风险
Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
估值高估
公司最新PE估值47.61,处于3年历史高位
机构减仓
最新机构持股49.87M股,环比减少0.00%
PRFDX持仓
明星投资者PRFDX持仓,最新持仓市值4.57K
活跃度增加
近期活跃度增加,过去20天平均换手率0.49

Bioventus Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Bioventus Inc简介

Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
公司代码BVS
公司Bioventus Inc
CEOClaypoole (Robert E)
网址https://www.bioventus.com/

常见问题

Bioventus Inc(BVS)的当前股价是多少?

Bioventus Inc(BVS)的当前股价是 7.460。

Bioventus Inc的股票代码是什么?

Bioventus Inc的股票代码是BVS。

Bioventus Inc股票的52周最高点是多少?

Bioventus Inc股票的52周最高点是11.250。

Bioventus Inc股票的52周最低点是多少?

Bioventus Inc股票的52周最低点是5.810。

Bioventus Inc的市值是多少?

Bioventus Inc的市值是499.62M。

Bioventus Inc的净利润是多少?

Bioventus Inc的净利润为-33.54M。

现在Bioventus Inc(BVS)的股票是买入、持有还是卖出?

根据分析师评级,Bioventus Inc(BVS)的总体评级为买入,目标价格为15.000。

Bioventus Inc(BVS)股票的每股收益(EPS TTM)是多少

Bioventus Inc(BVS)股票的每股收益(EPS TTM)是0.157。
KeyAI